A weak heart produces a poor appetite

July 12, 2012

Heart-brain-stomach link of major importance for diabetes and heart failure discovered: as a recent study by the MedUni Vienna has demonstrated, the hormone BNP, generated by the heart, also has an appetite-inhibiting effect. This discovery may open up new therapeutic opportunities for people with chronic heart failure or diabetes.

The heart not only responds to hormones, but it also produces some of these messenger substances itself. In patients with heart failure (weak hearts), increased levels of the BNP (B-type natriuretic peptide) are released. When produced in greater quantities, this hormone supports the heart’s action: not only do the kidneys excrete more sodium and fluid, but the vessels also dilate. The clear relationship between chronic and loss of appetite and the dramatic loss of weight was already known about, and determining the reason behind it would represent an important new discovery.

“Heart hormone” BNP has an appetite-suppressing effect

A team at the MedUni Vienna led by Martin Clodi from the Clinical Department of Endocrinology and Metabolic Diseases has now been able to answer this question. The hormone BNP is the culprit, since it has a direct -suppressing effect. The mechanism behind it is also described by the study, which has just been published in the internationally leading magazine “Diabetes”.

Newly-discovered “heart-brain-stomach link” opens up new therapeutic possibilities

Until now, all that was known was that there was a bi-directional connection between the brain and the gastrointestinal tract. This “brain- link” is also one of the key triggers for the chronic conditions of irritable bowel syndrome and dyspepsia. “The heart-brain-stomach link that has now been discovered apparently appears to exchange vital information with the brain and regulate key physical functions and, in , clearly makes it easier for the heart to work effectively by reducing the patient's weight. This will open up interesting perspectives for new treatment concepts in and diabetes," says Clodi.

Explore further: Peptide level ups diagnosis of heart failure in primary care

More information: B-type natriuretic peptide modulates ghrelin, hunger and satiety in healthy men. Vila G, Grimm G, Resl M, Heinisch BB, Einwallner E, Esterbauer H, Dieplinger B, Mueller T, Luger A, Clodi M. Diabetes, June 14, 2012, doi: 10.2337/db11-1466

Related Stories

Peptide level ups diagnosis of heart failure in primary care

May 15, 2012
(HealthDay) -- For patients presenting with dyspnea, the additional measurement of B-type natriuretic peptide (BNP) levels increases the certainty of diagnosis of heart failure and accelerates initiation of appropriate treatment, ...

One cause of fatty deposits in the hearts of diabetes patients settled

April 16, 2012
The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, Austrian researchers at the ...

Heart failure linked to thinner bones and fractures

February 2, 2012
Heart failure is associated with a 30 percent increase in major fractures and also identifies a high-risk population that may benefit from increased screening and treatment for osteoporosis, according to a recent study accepted ...

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.